INTS$3.38-1.55%
Intensity Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$11.03M
Float & O/S:
Inst Own:
DilutionScan read 21 of INTENSITY THERAPEUTICS, INC.'s SEC filings and found 7 warrant series, 1 ATM program, 2 shelf registrations, 2 S-1 registrations and 1 completed offering on file for INTS. The latest dilution event on file is ATM sales on Aug 11, 2026. Analysis updated Oct 6, 2026.
